NCT06910670NARecruiting
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Washington University School of Medicine
Start Date
4/3/2025
Completion Date
12/31/2026
Summary
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).
Eligibility Criteria
Age Range: 18 years to No maximum
Eligibility Criteria:
* Enrolled in the WU-PE-CGS study (IRB#202106129); that eligibility entails:
* Diagnosis of cholangiocarcinoma
* Diagnosis of multiple myeloma, must be African American
* Diagnosis of colorectal cancer, must be African American and age 65 or older at time of diagnosis
* At least 18 years old.
* Able to understand an IRB-approved informed consent document and agree to participation
* Have access to a personal computer, tablet or mobile device
Interventions
OTHER
Standard developed materials
OTHER
Genetics Advisor Decision Aid
Conditions
CholangiocarcinomaColorectal CancerMultiple Myeloma
Locations
Washington University School of Medicine
St Louis, Missouri 63110
United States